Buscar
Dexcom Inc
DXCMAñadir a la lista de seguimiento
83.450USD
+8.910+11.95%
Cierre 07-30 16:00（ET）Cotizaciones retrasadas 15 min
32.20BCap. mercado
34.89P/E TTM
Más Datos de Dexcom Inc Compañía
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.
Información de Dexcom Inc
Símbolo de cotizaciónDXCM
Nombre de la empresaDexcom Inc
Fecha de salida a bolsaApr 14, 2005
Director ejecutivoMr. Jacob Steven (Jake) Leach
Número de empleados10300
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 14
Dirección6340 Sequence Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Teléfono18582000200
Sitio Webhttps://www.dexcom.com/
Símbolo de cotizaciónDXCM
Fecha de salida a bolsaApr 14, 2005
Director ejecutivoMr. Jacob Steven (Jake) Leach
Ejecutivos de Dexcom Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Interim Principal Executive Officer, Chief Operating Officer, Director
President, Interim Principal Executive Officer, Chief Operating Officer, Director
321.97K
-0.45%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
64.19K
+0.82%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
61.90K
-2.34%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
57.45K
+1.04%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
40.69K
+1.30%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
38.99K
+1.36%
Ms. Bridgette P. Heller
Ms. Bridgette P. Heller
Independent Director
Independent Director
30.58K
+14.92%
Mr. Kyle Malady
Mr. Kyle Malady
Independent Director
Independent Director
28.24K
+19.74%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Independent Director
Independent Director
15.98K
+35.07%
Ms. Renee D. Gala
Ms. Renee D. Gala
Independent Director
Independent Director
8.67K
+64.63%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jacob Steven (Jake) Leach
Mr. Jacob Steven (Jake) Leach
President, Interim Principal Executive Officer, Chief Operating Officer, Director
President, Interim Principal Executive Officer, Chief Operating Officer, Director
321.97K
-0.45%
Mr. Steven R. (Steve) Altman
Mr. Steven R. (Steve) Altman
Independent Director
Independent Director
64.19K
+0.82%
Mr. Jereme M. Sylvain
Mr. Jereme M. Sylvain
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
61.90K
-2.34%
Mr. Mark G. Foletta
Mr. Mark G. Foletta
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
57.45K
+1.04%
Mr. Richard Alexander Collins
Mr. Richard Alexander Collins
Independent Director
Independent Director
40.69K
+1.30%
Mr. Nicholas (Nick) Augustinos
Mr. Nicholas (Nick) Augustinos
Independent Director
Independent Director
38.99K
+1.36%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Dexcom Inc?
Los cinco principales accionistas de Dexcom Inc son: Mr. Jacob Steven (Jake) Leach
¿Cuántas instituciones poseen acciones de Dexcom Inc (DXCM)?
A fecha de 2026Q1, 2227 instituciones poseen acciones de Dexcom Inc, con un valor de mercado combinado de aproximadamente 384.48M, lo que representa el 99.64% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -24085834.00.
¿Cuál es la mayor fuente de ganancias de Dexcom Inc?
El 2026Q1, el segmento empresarial Distributor generó la ganancia más alta para Dexcom Inc, ascendiendo a 3.96B y representando el 84.92% de la ganancia total.